Neuren Pharmaceuticals Limited (OTCMKTS:NURPF – Get Free Report) was the recipient of a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 288,479 shares, a growth of 185.6% from the October 15th total of 101,010 shares. Based on an average trading volume of 1 shares, the short-interest ratio is presently 288,479.0 days.
Neuren Pharmaceuticals Stock Performance
OTCMKTS NURPF remained flat at C$13.76 during mid-day trading on Friday. The business has a 50 day simple moving average of C$14.51 and a two-hundred day simple moving average of C$11.66. Neuren Pharmaceuticals has a fifty-two week low of C$7.70 and a fifty-two week high of C$17.25.
Neuren Pharmaceuticals Company Profile
Featured Stories
- Five stocks we like better than Neuren Pharmaceuticals
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for Neuren Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuren Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
